Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Munoz C
,
Saxena A
,
Pakladok T
,
Bogatikov E
,
Wilmes J
,
Seebohm G
,
Föller M
,
Lang F
.
???displayArticle.abstract???
The multifunctional protein ß-catenin governs as transcription factor the expression of a wide variety of genes relevant for cell proliferation and cell survival. In addition, ß-catenin is localized at the cell membrane and may influence the function of channels. The present study explored the possibility that ß-catenin participates in the regulation of the HERG K(+) channel. To this end, HERG was expressed in Xenopus oocytes with or without ß-catenin and the voltage-gated current determined utilizing the dual electrode voltage clamp. As a result, expression of ß-catenin markedly upregulated HERG channel activity, an effect not sensitive to inhibition of transcription with actinomycin D (10 µM). According to chemiluminescence, ß-catenin may increase HERG channel abundance within the oocytecell membrane. Following inhibition of channel insertion into the cell membrane by brefeldin A (5 µM) the decay of current was similar in oocytes expressing HERG together with ß-catenin to oocytes expressing HERG alone. The experiments uncover a novel function of APC/ß-catenin, i.e. the regulation of HERG channels.
???displayArticle.pubmedLink???
22905262
???displayArticle.pmcLink???PMC3419702 ???displayArticle.link???PLoS One
Figure 2. The effect of Ã-catenin on HERG currents is not modified by actinomycin D.Arithmetic means±SEM (nâ=â9â13) of the normalized outward tail current following a depolarization to +80 mV recorded in oocytes injected with cRNA encoding HERG (white bars) or with RNA encoding HERG and Ã-catenin (black bars), incubated for 24 hours without (left bars) or with (right bars) 10 µM actinomycin D prior to the measurement. *indicates statistical significance (p<0.05) from the absence of Ã-catenin cRNA.
Figure 3. Ã-catenin increases the surface abundance of HERG.Arithmetic means±SEM (nâ=â19â56) of the normalized HA-dependent surface chemiluminescence of oocytes injected with H20 (1st bar), with cRNA encoding Ã-catenin (2nd bar), encoding HERG (3rd bar) or encoding both, HERG and Ã-catenin (4th bar). ***indicates statistical significance (p<0.001) from the absence of Ã-catenin cRNA.
Figure 4. The effect of Brefeldin A on Ã-catenin-stimulated HERG currents.Arithmetic means±SEM (nâ=â15â19) of the normalized outward tail current following depolarization to +80 mV recorded in oocytes injected with cRNA encoding HERG (white bars) or with cRNA encoding HERG and Ã-catenin (black bars), prior to (0 days) and following incubation for 24 hours (1 day) or 48 hours (2 days) with 5 µM Brefeldin A prior to the measurement. **, ***indicate statistical significance (p<0.01, p<0.001) from the absence of Ã-catenin cRNA.
Figure 5. HERG currents are insensitive to truncated Ã-catenin1â530 and stimulated by N-cadherin.Arithmetic means ± SEM (nâ=â10â20) of the normalized outward tail current following depolarization to +80 mV and recorded in oocytes injected with water (white bar), or with cRNA encoding HERG (dark grey bar) with Ã-catenin (first black bar) or with the truncated mutant Ã-catenin1â530 (second black bar), without and with co-expression of N-cadherin (dotted dark grey bars). *, ***indicate statistical significance (p<0.05, p<0.001) from the absence of HERG cRNA, # (p<0.05) indicates statistical significance from the absence of N-cadherin.
Figure 1. Ã-catenin increases HERG current.
A. Original tracings recorded in oocytes injected with H20 (1), with cRNA encoding HERG (2) or HERG coexpressing Ã-catenin (3). The oocytes were depolarized from â80 mV holding potential to different voltages followed by a 500 ms pulse to â60 mV evoking outward tail currents. The small insert displays the applied voltage protocol. B. Arithmetic means±SEM (nâ=â8â11) of the normalized outward tail current following a depolarization to +80 mV recorded in oocytes injected with H20 (left bar), with cRNA encoding HERG (middle bar) or with RNA encoding HERG and Ã-catenin (right bar). * indicates statistical significance (p<0.05) from the absence of Ã-catenin cRNA. C. IV curves of outward tail currents illustrated in B (upper panel) and IV curves of outward tail currents following normalization to the maximal tail current of the respective group (lower panel).
Ai,
Wnt-1 regulation of connexin43 in cardiac myocytes.
2000, Pubmed
Ai,
Wnt-1 regulation of connexin43 in cardiac myocytes.
2000,
Pubmed
Alesutan,
Regulation of the glutamate transporter EAAT4 by PIKfyve.
2010,
Pubmed
,
Xenbase
Arcangeli,
Expression and role of hERG channels in cancer cells.
2005,
Pubmed
Asher,
Eag and HERG potassium channels as novel therapeutic targets in cancer.
2010,
Pubmed
Bergmann,
WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development.
2010,
Pubmed
Blankesteijn,
The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy.
2008,
Pubmed
Cadigan,
Wnt signaling: complexity at the surface.
2006,
Pubmed
Coussen,
Recruitment of the kainate receptor subunit glutamate receptor 6 by cadherin/catenin complexes.
2002,
Pubmed
Covey,
Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer.
2010,
Pubmed
Croce,
Evolution of the Wnt pathways.
2008,
Pubmed
Dehner,
Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
2008,
Pubmed
Dërmaku-Sopjani,
Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho.
2011,
Pubmed
,
Xenbase
Es-Salah-Lamoureux,
Fluorescence-tracking of activation gating in human ERG channels reveals rapid S4 movement and slow pore opening.
2010,
Pubmed
,
Xenbase
Fagotto,
Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus.
1996,
Pubmed
,
Xenbase
Flaherty,
Noncanonical Wnt11 signaling and cardiomyogenic differentiation.
2008,
Pubmed
,
Xenbase
Grigoryan,
Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice.
2008,
Pubmed
He,
Identification of c-MYC as a target of the APC pathway.
1998,
Pubmed
Heallen,
Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size.
2011,
Pubmed
Hirotani,
Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
2007,
Pubmed
Hirschy,
Stabilised beta-catenin in postnatal ventricular myocardium leads to dilated cardiomyopathy and premature death.
2010,
Pubmed
Hosseinzadeh,
Regulation of the glutamate transporters by JAK2.
2011,
Pubmed
,
Xenbase
Hu,
Down-regulation of the human ether-a-go-go-related gene in rat cardiac hypertrophy.
2011,
Pubmed
Jin,
Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
2008,
Pubmed
Koutsouki,
Modulation of human Kv1.5 channel kinetics by N-cadherin.
2007,
Pubmed
,
Xenbase
Kuwabara,
Granulocyte colony-stimulating factor activates Wnt signal to sustain gap junction function through recruitment of beta-catenin and cadherin.
2007,
Pubmed
Lesage,
Association of beta-catenin with the alpha-subunit of neuronal large-conductance Ca2+-activated K+ channels.
2004,
Pubmed
Maier,
Upregulation of HERG channels by the serum and glucocorticoid inducible kinase isoform SGK3.
2006,
Pubmed
,
Xenbase
Masuelli,
Beta-catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts.
2003,
Pubmed
Munoz,
Activation of voltage gated K⁺ channel Kv1.5 by β-catenin.
2012,
Pubmed
,
Xenbase
Naishiro,
Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
2005,
Pubmed
Nebenführ,
Brefeldin A: deciphering an enigmatic inhibitor of secretion.
2002,
Pubmed
Rao,
An updated overview on Wnt signaling pathways: a prelude for more.
2010,
Pubmed
Rochais,
Signaling pathways controlling second heart field development.
2009,
Pubmed
Sanguinetti,
Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia.
1999,
Pubmed
Schroen,
Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy.
2007,
Pubmed
Schumann,
Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression.
2000,
Pubmed
Sopjani,
Stimulation of Na+/K+ ATPase activity and Na+ coupled glucose transport by β-catenin.
2010,
Pubmed
,
Xenbase
Strutz-Seebohm,
Structural basis of slow activation gating in the cardiac I Ks channel complex.
2011,
Pubmed
,
Xenbase
ter Horst,
The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand?
2012,
Pubmed
Tetsu,
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
1999,
Pubmed
Vallon,
SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment.
2006,
Pubmed
Vallorosi,
Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution.
2000,
Pubmed
van Noort,
Wnt signaling controls the phosphorylation status of beta-catenin.
2002,
Pubmed
Vincent,
The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
1998,
Pubmed
Wang,
Inhibition of the rapid component of the delayed rectifier potassium current in ventricular myocytes by angiotensin II via the AT1 receptor.
2008,
Pubmed
Wang,
Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator.
2004,
Pubmed
Wilmes,
Regulation of KCNQ1/KCNE1 by β-catenin.
2012,
Pubmed
,
Xenbase
Yao,
Targeting the Wnt/β-catenin signaling pathway in human cancers.
2011,
Pubmed